The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting

Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada

(2018) Finlay A McAlister et al.   BMJ Open

Evaluation of atrial fibrillation management and cardiovascular risk profile in atrial fibrillation patients: A cross-sectional survey

(2017) Gediminas Račkauskas et al.   Medicina-Lithuania

Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry

(2017) Mika Lehto et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Evaluation of atrial fibrillation management and cardiovascular risk profile in atrial fibrillation patients: A cross-sectional survey

(2017) Gediminas Račkauskas et al.   Medicina-Lithuania

The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis

(2017) Anne Sig Vestergaard et al.   PLoS One

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

(2016) Liane O. Dallalzadeh et al.   Journal of the American Heart Association

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

(2016) Fredrik Björck et al.   JAMA Cardiology

Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States

(2016) William L. Baker et al.   JOURNAL OF MANAGED CARE PHARMACY

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

(2016) Sylvia Haas et al.   PLoS One

Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry

(2015) Sean D. Pokorney et al.   AMERICAN HEART JOURNAL

Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink

(2015) Ana Filipa Macedo et al.   THROMBOSIS RESEARCH

The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: warfarin -tr

(2015) Ahmet Celik et al.   Anatolian Journal of Cardiology

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   CIRCULATION

Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013)

(2014)   CIRCULATION JOURNAL

Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin

(2013) Stavros Apostolakis et al.   CHEST

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

(2013) B. P. Krijthe et al.   EUROPEAN HEART JOURNAL

Evidence-Based Management of Anticoagulant Therapy

(2012) Anne Holbrook et al.   CHEST

Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries

(2012) Harriette G.C. Van Spall et al.   CIRCULATION

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients

(2011) Arlene Gallagher et al.   THROMBOSIS AND HAEMOSTASIS

Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)

(2010) A. J. ROSE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

(2010) Lars Wallentin et al.   LANCET

Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

(2008) Stuart J. Connolly et al.   CIRCULATION

Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature

(2008) G. Dolan et al.   CURRENT MEDICAL RESEARCH AND OPINION